Early detection and treatment of these common urological conditions will bring significant improvements in the quality of life of men, thus spreading awareness on this day, International Men's Day ...
A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...